Aastha Spintex Limited IPO GMP Today
Live GMP
Mainboard
Live Grey Market Premium today
Current Grey Market Premium
+โน22 (27.5%) ๐
Bidding Active Today ๐ข
Expected Listing Price
| Metric | Value |
|---|---|
| Issue Price (Upper Band) | โน80 |
| Current GMP | โน22 (27.5%) |
| Expected Listing Price | โน102 |
| Listing Gain per Lot | โน35200 |
GMP is unofficial and can change rapidly. Do not rely solely on GMP for investment decisions.
Open
Jun 29, 2026
Close
Jul 01, 2026
Allotment
Jul 02, 2026
Listing
Jul 06, 2026
Subscription Status
| Category | Subscription | Demand |
|---|---|---|
| Overall | 14.80x (Strong Demand) | ๐ฅ Strong |
Category-wise breakdowns are updated as data becomes available from exchanges.
Share GMP Data
เคนเคฟเคเคฆเฅ เคฎเฅเค เคเคพเคจเคเคพเคฐเฅ
Aastha Spintex Limited IPO GMP เคเค: Grey Market Premium +โน22 (27.5%) ๐ เคนเฅเฅค เคเคธเคเคพ เคฎเคคเคฒเคฌ เคนเฅ เคเคฟ unofficial market เคฎเฅเค เคถเฅเคฏเคฐ โน22 เคเฅ premium เคชเคฐ trade เคนเฅ เคฐเคนเฅ เคนเฅเคเฅค Expected listing price โน102 เคนเฅเฅค เคงเฅเคฏเคพเคจ เคฐเคเฅเค เคเคฟ GMP unofficial เคนเฅ เคเคฐ เคฌเคฆเคฒ เคธเคเคคเคพ เคนเฅเฅค
Frequently Asked Questions
Aastha Spintex Limited IPO Grey Market Premium (GMP) is currently +โน22 (27.5%) ๐. This indicates the premium at which IPO shares are trading in the unofficial grey market before listing.
Based on current GMP of +โน22 (27.5%) ๐, the expected listing price of Aastha Spintex Limited IPO is approximately โน102 per share (Issue price โน80 + GMP โน22).
GMP is an unofficial indicator from the grey market and should not be the sole basis for investment decisions. It reflects market sentiment but actual listing price may differ significantly. Always consider fundamentals and financials.
Aastha Spintex Limited IPO subscription status is 14.80x (Strong Demand). Total subscription times indicate overall demand from Retail, HNI, and QIB investors.
While a positive GMP indicates good market sentiment, investment decisions should also consider company fundamentals, financials, peer comparison, and your risk appetite. GMP alone is not sufficient for making investment decisions.